Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Rafael Gisbert"'
Autor:
Maria Vergara-Barberán, Alicia Monleón, Amparo Sanz-Marco, María Jesús Lerma-García, Miriam Beneito-Cambra, Carlos Vila, Gonzalo Blay, Rafael Gisbert, Isabel Fernández, M. Luz Cardona, José Ramón Pedro
Publikováno v:
EDULEARN Proceedings.
Autor:
Ernesto Dalli-Peydró, Rafael Gisbert-Criado, Nuria Amigó, Nuria Sanz-Sevilla, Juan Cosín-Sales
Publikováno v:
International journal of cardiology. 369
A 10-month strategy of cardiac telerehabilitation (CTR) improved outcomes over a standard centre-based cardiac rehabilitation (CBCR), as recently published. We hypothesised that prolonged telerehabilitation could also improve proinflammatory status a
Autor:
Tanja Fehm, Luc Dirix, Stefan Sleijfer, Paola Gazzaniga, José A. García-Sáenz, Carlos Caldas, Rita Zamarchi, Karthik V. Giridhar, Lorenzo Gerratana, Massimo Cristofanilli, Luis Manso, Dimitrios Mavroudis, Kostandinos Sideras, Meredith M. Regan, Zefei Jiang, Michail Ignatiadis, Rafael Gisbert-Criado, William E. Barlow, François-Clément Bidard, Thomas W. P. Friedl, Klaus Pantel, Evi Lianidou, Daniele Generali, Jean-Yves Pierga, Sabine Riethdorf, Tracy C. Yab, Mark Jesus M. Magbanua, Jose Vidal-Martinez, Jeffrey B. Smerage, Brigitte Rack, Hope S. Rugo, Catherine Alix-Panabières, Lisa A. Carey, Minetta C. Liu, Volkmar Müller, William Jacot, Wolfgang Janni, Elisabetta Munzone, Justin Stebbing, Leon W.M.M. Terstappen, Daniel F. Hayes
Publikováno v:
Cancer Research. 81:GS4-08
Background: Several studies suggest clinical utility of serial circulating tumor cell (CTC) enumeration as a means of assessing response status in metastatic breast cancer (MBC). The aim of this study is to conduct a comprehensive pooled analysis com
Autor:
Lorenzo Gerratana, Jean-Yves Pierga, James M Reuben, Andrew A Davis, Firas H Wehbe, Luc Dirix, Tanja Fehm, Franco Nolé, Rafael Gisbert-Criado, Dimitrios Mavroudis, Salvatore Grisanti, Jose A Garcia-Saenz, Justin Stebbing, Carlos Caldas, Paola Gazzaniga, Luis Manso, Rita Zamarchi, Marta Bonotto, Angela Fernandez de Lascoiti, Leticia De Mattos-Arruda, Michail Ignatiadis, Maria-Teresa Sandri, Daniele Generali, Carmine De Angelis, Sarah-Jane Dawson, Wolfgang Janni, Vicente Carañana, Sabine Riethdorf, Erich-Franz Solomayer, Fabio Puglisi, Mario Giuliano, Klaus Pantel, François-Clément Bidard, Massimo Cristofanilli
Publikováno v:
Scientia
Biomarker; Liquid biopsy; Machine learning Biomarcadores; Biopsia líquida; Aprendizaje automático Biomarcadors; Biòpsia líquida; Aprenentatge automàtic Despite the strong prognostic stratification of circulating tumor cells (CTCs) enumeration in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd28e762c51263f622c8e7d064b07334
http://hdl.handle.net/11368/3017431
http://hdl.handle.net/11368/3017431
Autor:
Salvatore Grisanti, Tanja Fehm, Daniele Generali, Jean-Yves Pierga, Dimitrios Mavroudis, Mario Giuliano, Leticia De Mattos-Arruda, Steven Van Laere, Lorenzo Gerratana, Francesca Consoli, Wolfgang Janni, Klaus Pantel, Luc Dirix, Stefan Michiels, Carlos Caldas, Annemie Rutten, Jorge S. Reis-Filho, Michail Ignatiadis, Dieter Peeters, Andrew M. Davis, Sarah-Jane Dawson, Jose Vidal-Martinez, Cristina Raimondi, Massimo Cristofanilli, Alfred Rademaker, Maria Teresa Sandri, Justin Stebbing, Rita Zamarchi, Franziska Meier-Stiegen, Elisabetta Munzone, Jonathan Krell, Vicente Carañana, Erich-Franz Solomayer, Laura Zorzino, Franco Nolè, Paola Gazzaniga, Eduardo Díaz-Rubio, Lauren Darrigues, Luc Cabel, Rafael Gisbert-Criado, Eleni Politaki, Sofia Agelaki, José A. García-Sáenz, Angela Fernandez de Lascoiti, Maria Rosa Cappelletti, Camillo Almici, Luis Manso, François-Clément Bidard, James M. Reuben
Publikováno v:
Critical reviews in oncology, hematology
Background: The heterogeneity of metastatic breast cancer (MBC) necessitates novel biomarkers allowing stratification of patients for treatment selection and drug development. We propose to use the prognostic utility of circulating tumor cells (CTCs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ef4c527220afcd22fd71cd8f94b62a
https://hdl.handle.net/11368/2935442
https://hdl.handle.net/11368/2935442
Autor:
Pierre Squifflet, S Sleijfers, D Peeters, Jorge S. Reis-Filho, A Fernandez de Lascoiti, Camillo Almici, Salvatore Grisanti, Daniele Generali, Nick Beije, Cristina Raimondi, L. De Mattos-Arruda, Carlos Caldas, J-Y Pierga, L.Y. Dirix, D. Mavroudis, Alberto Bottini, Pier Paolo Gazzaniga, Wolfgang Janni, F-C Bidard, Stefan Michiels, Jonathan Krell, Jose Vidal-Martinez, Rita Zamarchi, S-J Dawson, Laura Zorzino, Annemie Rutten, Franco Nolè, Sophia Agelaki, Francesca Consoli, JA Garcia-Saenz, Michail Ignatiadis, S. Van Laere, Elisabetta Munzone, Rafael Gisbert-Criado, E Solomayer, Eleni Politaki, M. T. Sandri, Eduardo Díaz-Rubio, Luis Manso, Justin Stebbing, Klaus Pantel, Tanja Fehm, Vicente Carañana, Franziska Meier-Stiegen
Publikováno v:
Cancer Research. 76:P2-08
Background: The European Pooled Analysis of CTC (EPAC) in metastatic breast cancer, based on 1,944 individual data from patients with various tumor types and clinical settings (Bidard et al, Lancet Oncol 2014), has established CTC count (CellSearch)
Autor:
Volkmar Mueller, M. Maestro, Denise M. Wolf, Justin Stebbing, Karsten Weber, Paul Blanche, Masakazu Toi, Antonio Llombart-Cussac, Alessandra Meddis, Andreas D. Hartkopf, Jun Horiguchi, Fabien Reyal, Randi R. Mathiesen, Olav Engebraaten, Charlotte Proudhon, Laura J. Esserman, Paul Cottu, Rafael Gisbert-Criado, José A. García-Sáenz, Patrice Viens, Koenraad d'Hollander, Sara Y. Brucker, François-Clément Bidard, Maria Rosa Cappelletti, Elin Borgen, John W. Park, Dominic Amara, Daisuke Takata, Klaus Pantel, Vicente Carañana, Jaco Kraan, Jessica B. Bowman Bauldry, Stefan Michiels, Noriyoshi Fujisawa, Eduardo Díaz-Rubio, Jose Vidal-Martinez, Hideaki Tokiniwa, Françoise Rothé, Bjørn Naume, Stefan Sleijfer, Anthony Lucci, Mandar Karhade, Aurélien Latouche, Michail Ignatiadis, Carolyn S. Hall, Sibylle Loibl, Florin-Andrei Taran, Daniele Generali, Jean-Yves Pierga, Sabine Riethdorf, Jeffrey B. Smerage, Wendy Onstenk, Rin Nagaoka, Laura Muinelo-Romay, Mark Jesus M. Magbanua
Publikováno v:
Journal of the National Cancer Institute, 110(6):djy018, 560-567. Oxford University Press
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
Consejo Superior de Investigaciones Científicas (CSIC)
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
Consejo Superior de Investigaciones Científicas (CSIC)
Background: We conducted a meta-analysis in nonmetastatic breast cancer patients treated by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (CTC) detection as a prognostic marker. Methods: We collected individ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7081fc5de0490a8b10de50cb8818794e
https://pure.eur.nl/en/publications/34dfe697-929d-471e-9878-18ec73f848c6
https://pure.eur.nl/en/publications/34dfe697-929d-471e-9878-18ec73f848c6
Autor:
Juan Cosín-Sales, Jorge Ruvira, Rafael Gómez Ribelles, Alicia M. Maceira, Francisco Buendía, Rafael Gisbert-Criado
Publikováno v:
Revista Española de Cardiología. 71:979-980
Autor:
Alicia M. Maceira, Rafael Gisbert-Criado, Rafael Gómez Ribelles, Jorge Ruvira, Francisco Buendía, Juan Cosín-Sales
Publikováno v:
Revista espanola de cardiologia (English ed.). 71(11)
Autor:
Jose Vidal-Martinez, J. Murado-Pardo, Ana Blasco, Silvia Calabuig-Fariñas, Javier Garde-Noguera, Sandra Gallach, Rafael Gisbert-Criado, Nuria Piera Molons, Jose Garcia Sanchez, Susana Torres Martinez, Beatriz Honrubia Peris, F. Zhang, Eloisa Jantus-Lewintre, Carlos Camps, Francisco Aparisi, Lauren Condori Farfan
Publikováno v:
Journal of Clinical Oncology. 37:e20685-e20685
e20685 Background: Immunotherapy with anti-PD1/PDL1 monoclonal antibodies has become the second line standard treatment for most patients diagnosed of advanced Non-Small-Cell lung cancer (NSCLC). The aim of this study is to assess the utility of circ